Mohammad Hossein Jabbarpoor Bonyadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammad Hossein Jabbarpoor Bonyadi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Mortaza Bonyadi
Center of Excellence for Biodiversity, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran
12 shared publications- Masoud Soheilian
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
11 shared publications Mehdi Yaseri
Department of Biostatistics and Epidemiology, Tehran University of Medical Sciences, Tehran, Iran
8 shared publications- Mehdi Yaseri
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
5 shared publications Masoud Soheilian
Ophthalmic Research Center
4 shared publications- Homayoun Nikkhah
Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran
3 shared publications
Latest Publications
- 2 March 2022
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 43 (4) , 1-4
Role of CFH Y402H and ARMS2 A69S polymorphisms in susceptibility to post rhegmatogenous retinal detachment macular complications
Rhegmatogenous retinal detachment (RRD) is the most common type of retinal detachment. Purpose of this study is to evaluate the possible association of ARMS2 (age-related macular susceptibility 2) A69S and CFH (complement factor H) Y402H polymorphisms with post-surgical macular complications. One hundred and two RRD patients with macular involvement and proliferative vitreoretinopathy grade A prospectively were enrolled in the study. All patients were genotyped for two polymorphisms of CFH Y402H and ARMS2 A69S by applying Polymerase Chain Reaction (PCR)—Restriction Fragment Length Polymorphism (RFLP). Scleral buckling or deep vitrectomy performed based on surgeon decision. Optical coherence tomography (OCT) for all patients was performed on three, six, and twelve months after operation. The ARMS2 A69S GT genotype showed significant association with postoperative cystoid macular edema (OR = 3.11, P = 0.039). Logistic regression analysis showed that the effect of ARMS2 GT vs GG genotype remained significant on CME after confounding factors correction. (ARMS2 GT vs GG OR = 4.79, p value = 0.035). No association was observed between studied genotypes and postoperative persistent subfoveal fluid, macular atrophy, and macular epiretinal membrane. The ARMS2 A69S GT genotype was significantly associated with postoperative cystoid macular edema in RRD cases with macular involvement.
- 2 March 2022
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 43 (4) , 1-4
Role of CFH Y402H and ARMS2 A69S polymorphisms in susceptibility to post rhegmatogenous retinal detachment macular complications
Rhegmatogenous retinal detachment (RRD) is the most common type of retinal detachment. Purpose of this study is to evaluate the possible association of ARMS2 (age-related macular susceptibility 2) A69S and CFH (complement factor H) Y402H polymorphisms with post-surgical macular complications. One hundred and two RRD patients with macular involvement and proliferative vitreoretinopathy grade A prospectively were enrolled in the study. All patients were genotyped for two polymorphisms of CFH Y402H and ARMS2 A69S by applying Polymerase Chain Reaction (PCR)—Restriction Fragment Length Polymorphism (RFLP). Scleral buckling or deep vitrectomy performed based on surgeon decision. Optical coherence tomography (OCT) for all patients was performed on three, six, and twelve months after operation. The ARMS2 A69S GT genotype showed significant association with postoperative cystoid macular edema (OR = 3.11, P = 0.039). Logistic regression analysis showed that the effect of ARMS2 GT vs GG genotype remained significant on CME after confounding factors correction. (ARMS2 GT vs GG OR = 4.79, p value = 0.035). No association was observed between studied genotypes and postoperative persistent subfoveal fluid, macular atrophy, and macular epiretinal membrane. The ARMS2 A69S GT genotype was significantly associated with postoperative cystoid macular edema in RRD cases with macular involvement.
- Open Access
- 10 March 2021
- Published by Springer Nature in Research Square
CFH Y402H and ARMS2 A69S Genes Polymorphism Role in Susceptibility to Rhegmatogenous Retinal Detachment and its Complications
Background: Rhegmatogenous retinal detachment (RRD) is the most common type of retinal detachment. Purpose of this study is to evaluate the possible association of ARMS2 A69S and CFH Y402H polymorphisms with RRD and its postoperative complications. Materials and Methods: Polymerase chain reaction for DNA replication followed by restriction fragment length polymorphism for enzyme digestion. RRD patients (102 cases) and healthy controls (150 individuals for ARMS2 and 94 individuals for CFH). The two polymorphisms were genotyped by Polymerase Chain Reaction (PCR) – Restriction Fragment Length Polymorphism (RFLP) in a case-control study of 102 RRD patients and 150 controls to evaluate the possible association of ARMS2 A69S and CFH Y402H polymorphism with RRD susceptibility.Results: The genotypes frequencies for ARMS2 A69S and CFH Y402H found to be significantly different between RRD and normal controls (ARMS2 A69S 42.1%vs 32.7%, OR =1.69, p< 0.036 for GT and, CFH Y402H 10.8% vs 6.4%, OR=4.17, p=0.01 for CC genotype and 67.6% vs 40.4%, OR=4.13, p< 0.0001 for CT genotype). The ARMS2 A69S GT genotype showed significant association with postoperative cystoid macular edema (CME) (OR=3.11, P = 0.0039).Conclusions: ARMS2 A69S and CFH Y402H showed significant association with RRD. The ARMS2 A69S GT genotype was also associated with postoperative cystoid macular edema.
- 10 March 2021
- Published by Springer Nature in Research Square
Open AccessCFH Y402H and ARMS2 A69S Genes Polymorphism Role in Susceptibility to Rhegmatogenous Retinal Detachment and its Complications
Background: Rhegmatogenous retinal detachment (RRD) is the most common type of retinal detachment. Purpose of this study is to evaluate the possible association of ARMS2 A69S and CFH Y402H polymorphisms with RRD and its postoperative complications. Materials and Methods: Polymerase chain reaction for DNA replication followed by restriction fragment length polymorphism for enzyme digestion. RRD patients (102 cases) and healthy controls (150 individuals for ARMS2 and 94 individuals for CFH). The two polymorphisms were genotyped by Polymerase Chain Reaction (PCR) – Restriction Fragment Length Polymorphism (RFLP) in a case-control study of 102 RRD patients and 150 controls to evaluate the possible association of ARMS2 A69S and CFH Y402H polymorphism with RRD susceptibility.Results: The genotypes frequencies for ARMS2 A69S and CFH Y402H found to be significantly different between RRD and normal controls (ARMS2 A69S 42.1%vs 32.7%, OR =1.69, p< 0.036 for GT and, CFH Y402H 10.8% vs 6.4%, OR=4.17, p=0.01 for CC genotype and 67.6% vs 40.4%, OR=4.13, p< 0.0001 for CT genotype). The ARMS2 A69S GT genotype showed significant association with postoperative cystoid macular edema (CME) (OR=3.11, P = 0.0039).Conclusions: ARMS2 A69S and CFH Y402H showed significant association with RRD. The ARMS2 A69S GT genotype was also associated with postoperative cystoid macular edema.
- 2 July 2020
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 41 (5) , 505-506
Association of Saitohin gene rs62063857 polymorphism with dry type age-related macular degeneration
Purpose: Age-related macular degeneration (AMD) as the leading cause of central visual loss in the developed countries has extensive pathologic similarities with Alzheimer’s disease (AD). Saitohin rs62063857 Q7 R polymorphism is associated with increased risk of AD though we decided to evaluate the possible association of this polymorphism with advanced AMD. Materials and Methods: 152 advanced AMD patients (134 wet AMD and 18 geographic atrophy) and 75 healthy controls included in this study. Cases and controls went through a standard ophthalmologic examination by a retinal specialist. Saitohin gene rs62063857 polymorphism determined by using PCR technique and restriction enzyme HinFI. To evaluate the differences between groups we used t-test, Chi-Squared and one-tailed Fisher exact test. Results: Distribution of genotypes was not significantly different between total AMD or wet AMD patients compared to that of controls (total AMD RR+QR: OR = 1.51, CI = 0.82–2.79, P = .12; wet AMD RR+QR: OR = 1.39, CI = 0.74–2.59, P = .19). The RR+QR genotypes were significantly higher in dry AMD group compared to that of controls (RR+QR: OR = 2.75, CI = 0.96–7.9, P = .05). Conclusion: Our results showed that although STH Q7 R polymorphism was not associated with wet AMD susceptibility it was significantly associated with geographic atrophy.
- 2 July 2020
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 41 (5) , 505-506
Association of Saitohin gene rs62063857 polymorphism with dry type age-related macular degeneration
Purpose: Age-related macular degeneration (AMD) as the leading cause of central visual loss in the developed countries has extensive pathologic similarities with Alzheimer’s disease (AD). Saitohin rs62063857 Q7 R polymorphism is associated with increased risk of AD though we decided to evaluate the possible association of this polymorphism with advanced AMD. Materials and Methods: 152 advanced AMD patients (134 wet AMD and 18 geographic atrophy) and 75 healthy controls included in this study. Cases and controls went through a standard ophthalmologic examination by a retinal specialist. Saitohin gene rs62063857 polymorphism determined by using PCR technique and restriction enzyme HinFI. To evaluate the differences between groups we used t-test, Chi-Squared and one-tailed Fisher exact test. Results: Distribution of genotypes was not significantly different between total AMD or wet AMD patients compared to that of controls (total AMD RR+QR: OR = 1.51, CI = 0.82–2.79, P = .12; wet AMD RR+QR: OR = 1.39, CI = 0.74–2.59, P = .19). The RR+QR genotypes were significantly higher in dry AMD group compared to that of controls (RR+QR: OR = 2.75, CI = 0.96–7.9, P = .05). Conclusion: Our results showed that although STH Q7 R polymorphism was not associated with wet AMD susceptibility it was significantly associated with geographic atrophy.
- 14 May 2020
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 41 (4) , 301-307
Association of combined complement factor H Y402H and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: an updated meta-analysis
Background: Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2/LOC387715A69 S-CFHY402 H genotypes and AMD to estimate the synergistic effects. Methods: Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. To estimate the additive or supra-additive effects we calculated RERI (relative excess risk due to interaction), AP (attributable proportion due to interaction), S (synergy index) and V (multiplicative index). Results: We included 12 studies with 4668 AMD patients and 4936 control subjects. Considering the GGTT genotypes as reference line, the pooled AMD odds ratios for stratified combined genotypes was 2.13 (95% CI 1.64–2.78) for GGnonTT, 2.17 (95% CI 1.63–2.89) for nonGGTT and 7.23 (95% CI 4.95–10.55) for nonGGnonTT. Pooled synergy analysis revealed RERI = 3.90 (95% CI 0.58–10.03), AP = .53 (95% CI 0.09–0.69), S = 2.57 (95% CI 1.27–5.22) and V = 1.47 (95% CI 1.21–1.80). Conclusion: This updated analysis showed a strong synergistic and positive multiplicative effect of these two genes indicating that there is common pathway of ARMS2/LOC387715 A69 S and CFH Y402 H in AMD pathogenesis which may be complement system pathway.
- 14 May 2020
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 41 (4) , 301-307
Association of combined complement factor H Y402H and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: an updated meta-analysis
Background: Complement factor H (CFH) Y402 H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2)/LOC387715 A69 S (rs10490924) polymorphisms shown to have significant association with AMD. In this meta-analysis, we updated and pooled the results of available association studies between combined ARMS2/LOC387715A69 S-CFHY402 H genotypes and AMD to estimate the synergistic effects. Methods: Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. To estimate the additive or supra-additive effects we calculated RERI (relative excess risk due to interaction), AP (attributable proportion due to interaction), S (synergy index) and V (multiplicative index). Results: We included 12 studies with 4668 AMD patients and 4936 control subjects. Considering the GGTT genotypes as reference line, the pooled AMD odds ratios for stratified combined genotypes was 2.13 (95% CI 1.64–2.78) for GGnonTT, 2.17 (95% CI 1.63–2.89) for nonGGTT and 7.23 (95% CI 4.95–10.55) for nonGGnonTT. Pooled synergy analysis revealed RERI = 3.90 (95% CI 0.58–10.03), AP = .53 (95% CI 0.09–0.69), S = 2.57 (95% CI 1.27–5.22) and V = 1.47 (95% CI 1.21–1.80). Conclusion: This updated analysis showed a strong synergistic and positive multiplicative effect of these two genes indicating that there is common pathway of ARMS2/LOC387715 A69 S and CFH Y402 H in AMD pathogenesis which may be complement system pathway.
- 23 April 2020
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 41 (3) , 235-239
Tumor necrosis factor (TNF)-308, -1031, and angiotensin-converting enzyme (ACE) DD/II polymorphisms’ role in Behcet’s disease with and without uveitis: a meta-analysis
Purpose: There are conflicting results of studies investigating the association between the tumor necrosis factor (TNF) and angiotensin-converting enzyme (ACE) gene polymorphisms and Behcet’s disease (BD). The aim of this meta-analysis is to assess the association between these gene polymorphisms and ocular involvement in BD. Methods: We identified relevant studies and reviewed the full-text manuscripts of the studies in order to select those for inclusion. Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. Results: We analyzed TNF-1031, −308 and ACE DD/II genotype difference between BD patients with and without uveitis. Among these polymorphic genetic loci TNF-308 AA genotype has a statistically significant protective effect against BD uveitis (OR = 0.45 vs 1.23, p = .017). Such a statistically significant effect was not seen for other studied genotypes. Conclusion: This meta-analysis revealed a significant protective effect of TNF-308 AA genotype against ocular involvement in Behcet’s disease.
- 23 April 2020
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 41 (3) , 235-239
Tumor necrosis factor (TNF)-308, -1031, and angiotensin-converting enzyme (ACE) DD/II polymorphisms’ role in Behcet’s disease with and without uveitis: a meta-analysis
Purpose: There are conflicting results of studies investigating the association between the tumor necrosis factor (TNF) and angiotensin-converting enzyme (ACE) gene polymorphisms and Behcet’s disease (BD). The aim of this meta-analysis is to assess the association between these gene polymorphisms and ocular involvement in BD. Methods: We identified relevant studies and reviewed the full-text manuscripts of the studies in order to select those for inclusion. Heterogeneity of studies was evaluated using Cochran Q-test and I-square index. To modify the heterogeneity in the variables we used random effects model. Meta-analysis was performed using STATA. Results: We analyzed TNF-1031, −308 and ACE DD/II genotype difference between BD patients with and without uveitis. Among these polymorphic genetic loci TNF-308 AA genotype has a statistically significant protective effect against BD uveitis (OR = 0.45 vs 1.23, p = .017). Such a statistically significant effect was not seen for other studied genotypes. Conclusion: This meta-analysis revealed a significant protective effect of TNF-308 AA genotype against ocular involvement in Behcet’s disease.
- 8 February 2018
- Published by Springer Nature in International Ophthalmology
- Vol. 39 (4) , 949-956
Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis
We designed this meta-analysis to pool studies which have analyzed both CFH (Y402H or I62V) and ARMS2 A69S in the same samples to compare the effect of CFH and ARMS2 in neovascular AMD.
- 8 February 2018
- Published by Springer Nature in International Ophthalmology
- Vol. 39 (4) , 949-956
Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis
We designed this meta-analysis to pool studies which have analyzed both CFH (Y402H or I62V) and ARMS2 A69S in the same samples to compare the effect of CFH and ARMS2 in neovascular AMD.
- 1 February 2018
- Published by Springer Nature in International Ophthalmology
- Vol. 39 (3) , 551-556
Association of polymorphisms of complement factor I rs141853578 (G119R) with age-related macular degeneration in Iranian population
Age-related macular degeneration (AMD) is a complex disease, and recent studies have shown role of complement system genes in its development. Complement factor I regulates the complement pathways, and relationship between CFI polymorphisms and AMD is controversial. We evaluated the possible association of complement factor I rs141853578 (G119R) variation with advanced AMD in Iranian patients.
- 1 February 2018
- Published by Springer Nature in International Ophthalmology
- Vol. 39 (3) , 551-556
Association of polymorphisms of complement factor I rs141853578 (G119R) with age-related macular degeneration in Iranian population
Age-related macular degeneration (AMD) is a complex disease, and recent studies have shown role of complement system genes in its development. Complement factor I regulates the complement pathways, and relationship between CFI polymorphisms and AMD is controversial. We evaluated the possible association of complement factor I rs141853578 (G119R) variation with advanced AMD in Iranian patients.
- Open Access
- 1 January 2018
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 13 (3) , 370-371
Author's reply
Journal of Ophthalmic and Vision Research,Iran
- 1 January 2018
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 13 (3) , 370-371
Open AccessAuthor's reply
Journal of Ophthalmic and Vision Research,Iran
- 31 October 2017
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 39 (2) , 189-193
Interactions among different genetic loci in age-related macular degeneration
Purpose: To evaluate the possible synergistic effect of at risk genotypes of ARMS2/LOC387715 (A69S), DNA repair SMUG1 rs3087404, CCL2–2518, C3 (R102G), CFH Y402H, complement factor B (L9H), and complement factor I (CFI) (G119R) in advanced age-related macular degeneration compared to those of healthy controls. Elucidation of synergistic effects between different genetic loci may clarify their pathogenetic pathways. Methods: We calculated relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (S) to estimate the additive or supra-additive effects of the mentioned genotypes. Results: ARMS2-CFH [RERI = 4.78 (95% CI 2.17–10.61), AP = 0.65 (95% CI 0.33–0.83), S = 4.11 (95% CI 1.40–12.06)], and CFH-C3 combinations [RERI = 2.71 (95% CI 0.04–7.01) AP = 0.47 (95% CI −0.03–0.7) S = 2.30 (95%CI 0.97–5.45)] have the most significant levels of synergism and C3-CFI combination [RERI = −1.65 (95%CI −4.34–0.06), AP = −0.92(95%CI −3.09 – −0.09), S = 0.32 (95%CI 0.09 = 1.20)] has the most significant level of antagonism. Conclusion: Among different genotype combinations ARMS2-CFH and CFH-C3 combinations have the most significant levels of synergism and C3-CFI combination has the most significant level of antagonism in AMD patients.
- 31 October 2017
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 39 (2) , 189-193
Interactions among different genetic loci in age-related macular degeneration
Purpose: To evaluate the possible synergistic effect of at risk genotypes of ARMS2/LOC387715 (A69S), DNA repair SMUG1 rs3087404, CCL2–2518, C3 (R102G), CFH Y402H, complement factor B (L9H), and complement factor I (CFI) (G119R) in advanced age-related macular degeneration compared to those of healthy controls. Elucidation of synergistic effects between different genetic loci may clarify their pathogenetic pathways. Methods: We calculated relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (S) to estimate the additive or supra-additive effects of the mentioned genotypes. Results: ARMS2-CFH [RERI = 4.78 (95% CI 2.17–10.61), AP = 0.65 (95% CI 0.33–0.83), S = 4.11 (95% CI 1.40–12.06)], and CFH-C3 combinations [RERI = 2.71 (95% CI 0.04–7.01) AP = 0.47 (95% CI −0.03–0.7) S = 2.30 (95%CI 0.97–5.45)] have the most significant levels of synergism and C3-CFI combination [RERI = −1.65 (95%CI −4.34–0.06), AP = −0.92(95%CI −3.09 – −0.09), S = 0.32 (95%CI 0.09 = 1.20)] has the most significant level of antagonism. Conclusion: Among different genotype combinations ARMS2-CFH and CFH-C3 combinations have the most significant levels of synergism and C3-CFI combination has the most significant level of antagonism in AMD patients.
- 8 June 2017
- Published by Wiley in Acta Ophthalmologica
- Vol. 96 (2) , e105-e110
Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age‐related macular degeneration with and without reticular pseudodrusen: a meta‐analysis
To pool the results of published data regarding association of ARMS2/LOC387715 A69S, CFH Y402H and CFH I62V genotypes with age‐related macular degeneration (AMD) with and without reticular pseudodrusen (RPD). The results of this pooled data used to estimate the contribution of each of these genes in the pathogenesis of RPD. Heterogeneity of studies was evaluated using Cochran Q‐test and I2 index. To modify the heterogeneity in the variables, we used the random effects model. Meta‐analysis was performed using STATA. Odds ratio (OR) of genotypes in each study was calculated. Six studies of AMD with RPD and AMD without RPD cases included in this analysis. Analysis of pooled data showed that risk genotypes frequency of ARMS2 A69S was significantly different between AMD with RPD and AMD without RPD [OR = 1.82, 95% confidence interval (CI): 1.26–2.63 for GT versus GG ARMS2 A69S; OR = 2.40, 95% CI: 1.50–3.84 for TT versus GG ARMS2 A69S]. Further analysis also showed that the risk genotype frequency of CFH Y402H was not significantly different between these two groups (OR = 1.02, 95% CI: 0.69–1.50 for CT versus TT CFH Y402H; OR = 1.09, 95% CI: 0.74–1.60 for CC versus TT CFH Y402H). Comparison of above‐mentioned ORs revealed statistically higher values for GT and TT genotypes of ARMS2 A69S compared with CFH Y402H genotypes (p = 0.011, p = 0.014, respectively).Our analysis showed stronger contribution of ARMS2 in AMD with RPD group versus AMD without RPD group, in comparison with CFH genotypes.
- 8 June 2017
- Published by Wiley in Acta Ophthalmologica
- Vol. 96 (2) , e105-e110
Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age‐related macular degeneration with and without reticular pseudodrusen: a meta‐analysis
To pool the results of published data regarding association of ARMS2/LOC387715 A69S, CFH Y402H and CFH I62V genotypes with age‐related macular degeneration (AMD) with and without reticular pseudodrusen (RPD). The results of this pooled data used to estimate the contribution of each of these genes in the pathogenesis of RPD. Heterogeneity of studies was evaluated using Cochran Q‐test and I2 index. To modify the heterogeneity in the variables, we used the random effects model. Meta‐analysis was performed using STATA. Odds ratio (OR) of genotypes in each study was calculated. Six studies of AMD with RPD and AMD without RPD cases included in this analysis. Analysis of pooled data showed that risk genotypes frequency of ARMS2 A69S was significantly different between AMD with RPD and AMD without RPD [OR = 1.82, 95% confidence interval (CI): 1.26–2.63 for GT versus GG ARMS2 A69S; OR = 2.40, 95% CI: 1.50–3.84 for TT versus GG ARMS2 A69S]. Further analysis also showed that the risk genotype frequency of CFH Y402H was not significantly different between these two groups (OR = 1.02, 95% CI: 0.69–1.50 for CT versus TT CFH Y402H; OR = 1.09, 95% CI: 0.74–1.60 for CC versus TT CFH Y402H). Comparison of above‐mentioned ORs revealed statistically higher values for GT and TT genotypes of ARMS2 A69S compared with CFH Y402H genotypes (p = 0.011, p = 0.014, respectively).Our analysis showed stronger contribution of ARMS2 in AMD with RPD group versus AMD without RPD group, in comparison with CFH genotypes.